Foghorn Therapeutics Stock Target Price and Analyst Consensus

FHTX Stock  USD 4.34  0.36  9.05%   
The current analyst and expert consensus on Foghorn Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected Foghorn Therapeutics target price consensus is 12.00 with 7 analyst opinions. Check out Macroaxis Advice on Foghorn Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.
The most common way Foghorn Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Foghorn Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Foghorn Therapeutics. We strongly encourage you to use your own analysis of Foghorn Therapeutics to validate this buy or sell advice. Foghorn Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Foghorn Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.1638.
Lowest Forecast
10.92
Highest Forecast
13.32
Target Price
12
Gross Profit is likely to rise to about (64.6 M) in 2025. Pretax Profit Margin is likely to drop to -2.61 in 2025. At this time, Foghorn Therapeutics' Other Current Liabilities is fairly stable compared to the past year. Total Current Liabilities is likely to rise to about 87.8 M in 2025, whereas Total Assets are likely to drop slightly above 280.8 M in 2025.
  
It's important to approach Foghorn Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Foghorn Therapeutics Target Price Consensus

Foghorn target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Foghorn Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   7  Strong Buy
Most Foghorn analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Foghorn stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Foghorn Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Foghorn Therapeutics Target Price Projection

Foghorn Therapeutics' current and average target prices are 4.34 and 12.00, respectively. The current price of Foghorn Therapeutics is the price at which Foghorn Therapeutics is currently trading. On the other hand, Foghorn Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Foghorn Therapeutics Market Quote on 31st of January 2025

Low Price4.05Odds
High Price4.46Odds

4.34

Target Price

Analyst Consensus On Foghorn Therapeutics Target Price

Low Estimate10.92Odds
High Estimate13.32Odds

12.0

Historical Lowest Forecast  10.92 Target Price  12.0 Highest Forecast  13.32
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Foghorn Therapeutics and the information provided on this page.

Foghorn Therapeutics Analyst Ratings

Foghorn Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Foghorn Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Foghorn Therapeutics' financials, market performance, and future outlook by experienced professionals. Foghorn Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Foghorn Therapeutics price targets

Foghorn Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Foghorn Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Foghorn Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Foghorn Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Foghorn Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Foghorn Therapeutics is a key component of Foghorn Therapeutics valuation and have some predictive power on the future returns of a Foghorn Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Foghorn Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.015.179.33
Details
Intrinsic
Valuation
LowRealHigh
2.056.2110.37
Details
Naive
Forecast
LowNextHigh
0.034.198.35
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.45-0.39-0.34
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 300 shares
Business Services Idea
Business Services
Invested over 100 shares
Blockchain Idea
Blockchain
Invested few shares
Banking Idea
Banking
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 300 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.